Hey Don,
here is my list...
* Hedging (even though it is a very known issue and RRL are doing a good job at mitigating it with their slow selling into it).
* The company did not increase its dividend even though it is likely to have a very good influx of cash in 2020. Perhaps they are saving capital for when McP finally gets the go ahead (permitting is clearly a nightmare due to NSW gov...)
* McP has not progressed as planned, as it was originally planned to be in production this year...... 200k p.a of production sitting and not producing.
* RRL is starting to head U/G for the first time.... perhaps some small element of risk?
* The stock is boring... there I said it. They have only recently started to really explore their current tenements.
* ASIC has increased when for many years they had the lowest ASIC in the mid tiers.
* Management - after the failed tilt at CMM, I feel the 'market' has decided that RRL, whilst a proven producer, is not the same pedigree as NST/EVN/SAR.
That being said, I bought a few today. Probably buy more in the coming weeks. The dividend alone is enticement enough, yet... with POG now hitting A$2500. Even with their crappy hedging, they are going to make a huge amount of money. Plus, their production is going to incrementally increase over coming years, towards 400k p.a. I also like that its under-performed its peers, not because of production issues, but again, because its boring. I am ok with boring when the global headwinds seem particularly turbulent.
- Forums
- ASX - By Stock
- Posts record profits despite lower WA gold production
RRL
regis resources limited
Add to My Watchlist
1.37%
!
$4.45

Hey Don,here is my list...* Hedging (even though it is a very...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.45 |
Change
0.060(1.37%) |
Mkt cap ! $3.361B |
Open | High | Low | Value | Volume |
$4.50 | $4.56 | $4.43 | $12.26M | 2.742M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $4.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.46 | 21218 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 4.440 |
3 | 21218 | 4.410 |
1 | 16126 | 4.400 |
1 | 16126 | 4.390 |
1 | 6000 | 4.380 |
Price($) | Vol. | No. |
---|---|---|
4.460 | 21218 | 3 |
4.470 | 16126 | 1 |
4.480 | 16126 | 1 |
4.500 | 10000 | 1 |
4.520 | 915 | 1 |
Last trade - 16.11pm 01/07/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online